CERS vs CPB · rev $201.3M vs P/E 12, rev $10.25B
Cerus Corporation (CERS) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
CERS currently screens at market cap $294.4M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the CERS and CPB stock pages for the full models.
Not investment advice.